Vyant Bio Profit Margin

The latest profit margin for VYNT is -4310.36% as of December 2022. That compares with -3559.15% in the prior-year period — down 21.1% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Vyant Bio's historical trend and sector peers before judging valuation or financial health.

Over the past year, VYNT's profit margin moved from -3559.15% to -4310.36% — a 21.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Vyant Bio's valuation or profitability profile.

Against Healthcare companies, VYNT currently prints -4310.36% for profit margin, while the sector average sits near 15.58%. That is roughly 27758.8% below the sector mean. Large gaps often invite a closer look at Vyant Bio's growth, margins, and balance sheet.

Profit Margin shows how effectively Vyant Bio converts resources into returns. At -4310.36%, VYNT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3559.15% in the prior-year period — down 21.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting VYNT's profit margin (-4310.36%), review year-over-year change from -3559.15%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.